| Literature DB >> 35877592 |
Jan Stassen1,2, Aniek L van Wijngaarden1, Hoi W Wu1, Meindert Palmen3, Anton Tomsic3, Victoria Delgado1, Jeroen J Bax1,4, Nina Ajmone Marsan1.
Abstract
Left atrial (LA) dilatation is associated with worse outcomes in primary mitral regurgitation (MR). However, the effects of mitral valve repair on LA size and its prognostic implications are not well known. In the current study, LA volume index (LAVi) and LA reservoir strain (LASr) were evaluated immediately before and after surgery, and during long-term follow-up in 226 patients undergoing mitral valve repair for primary MR (age 62 ± 13 years, 66% male). Mean LAVi was reduced significantly after surgery and at long-term follow-up (from 56 ± 28 to 38 ± 21 to 32 ± 17 mL/m2; p < 0.001). LASr reduced significantly after surgery but increased again during the long-term (from 23.6 ± 9.4 to 11.5 ± 5.0 to 17.3 ± 7.5%; p < 0.001). Age, pre-operative LAVi, MR severity, and postoperative transmitral pressure gradient were associated with LA reverse remodeling by the long-term check-up. During a median follow-up of 72 (40-114) months, 43 (19%) patients died. Patients with LAVi ≥ 42 mL/m2 at long-term follow-up showed significant higher mortality rates compared to patients with LAVI < 42 mL/m2 (p < 0.001), even after adjusting for clinical covariates. In conclusion, significant LA reverse remodeling was observed both immediately and at long-term follow-up after mitral valve repair. LA dilatation at long term follow-up after surgery was still associated with all-cause mortality.Entities:
Keywords: left atrial remodeling; left atrium volume index; mitral valve repair; mortality; primary mitral regurgitation
Year: 2022 PMID: 35877592 PMCID: PMC9320730 DOI: 10.3390/jcdd9070230
Source DB: PubMed Journal: J Cardiovasc Dev Dis ISSN: 2308-3425
Figure 1Measurements of left atrial volume and left atrial reservoir strain in a patient with significant primary mitral regurgitation. The figure shows a patient with significant primary MR (A) who had an enlarged LAVi (measured according to the biplane Simpson method) (B) and reduced LASr (measured as the peak value from the LA strain versus time curve derived from the 4-chamber view) (C). Regional strain curves are represented by different colors (yellow, red, blue, pink, green, light blue).
Baseline clinical and echocardiographic characteristics of the total study population.
| Study Population ( | |
|---|---|
| Clinical characteristics | |
| Age, years | 62.2 ± 12.6 |
| Male sex | 149 (65.9%) |
| Heart rate, bpm | 76 ± 23 |
| Systolic BP, mmHg | 134 ± 20 |
| Diastolic BP, mmHg | 78 ± 11 |
| BMI, kg/m2 | 25.2 ± 3.5 |
| Arterial hypertension | 86 (38.1%) |
| Diabetes mellitus | 4 (1.8%) |
| (ex)smoker | 69 (32.9%) |
| Coronary artery disease | 44 (20.0%) |
| COPD | 15 (6.8%) |
| eGFR, mL/min/1.73 m2 | 81.5 ± 25.2 |
| CKD (eGFR < 60 mL/min/1.73 m2) | 44 (19.6%) |
| Atrial fibrillation | 75 (33.2%) |
| NYHA class ≥ II | 165 (73.0%) |
| Mitral valve lesion and associated surgical procedures | |
| Prolapsing leaflet | |
| Anterior | 26 (11.5%) |
| Posterior | 161 (71.%2) |
| Both | 39 (17.3%) |
| Associated surgical procedures | |
| CABG | 35 (15.5%) |
| TVP | 113 (50.0%) |
| MAZE | 64 (28.3%) |
| LAA occlusion | 30 (13.3%) |
| Echocardiographic characteristics | |
| LVEDD, mm | 54.5 ± 6.6 |
| LVESD, mm | 33.4 ± 7.0 |
| LVEDVi, mL/m2 | 71 ± 19 |
| LVESVi, mL/m2 | 24 (19–31) |
| LVEF, % | 65 ± 8 |
| sPAP, mmHg | 32 (25–45) |
| MR EROA, mm2 | 41 (29–55) |
| MR vena contracta, mm | 7.2 ± 1.8 |
| MR Rvol, mL | 55 ± 23 |
| LAVi, mL/m2 | 56 ± 28 |
| LASr, % | 23.6 ± 9.4 |
Values are presented as mean ± SD, median (IQR), or n (%). BMI = body mass index; BP = blood pressure; bpm = beats per minute; CABG = coronary artery bypass grafting; CKD = chronic kidney disease (defined as eGFR < 60 mL/min/1.73 m2); COPD = chronic obstructive pulmonary disease; eGFR = estimated glomerular filtration rate; EROA = effective regurgitant orifice area; LAA = left atrial appendage; LASr = left atrial reservoir strain; LAVi = left atrial volume index; LVEDD = left ventricular end diastolic diameter; LVEDVi = left ventricular end diastolic volume index; LVEF = left ventricular ejection fraction; LVESD = left ventricular end systolic diameter; LVESVi = left ventricular end systolic volume index; MR = mitral regurgitation; NYHA = New York Heart Association; Rvol = regurgitant volume; sPAP = systolic pulmonary artery pressure; TVP = tricuspid valve annuloplasty.
Figure 2Changes in left atrium volume index (A) and left atrium reservoir strain (B) over time. Panel A shows the changes in LAVi among baseline, postoperative, and long-term follow-up values. Panel B shows the changes in LASr among baseline, postoperative, and long-term follow-up values. LASr = left atrial reservoir strain; LAVi = left atrium volume index; TTE = transthoracic echocardiography.
Figure 3Changes in left atrium volume index over time according to the degree of preoperative left atrial dilatation. Changes in LAVi over time, according to three groups: patients with preoperativee LAVi < 42 mL/m2 (n = 68); patients with preoperative LAVi 42–59 mL/m2 (n = 88); patients with preoperative LAVi ≥ 60 mL/m2 (n = 70). LAVi = left atrium volume index; TTE = transthoracic echocardiography.
Changes in echocardiographic variables at long-term follow-up after mitral valve repair.
| Pre-Operative | Long-Term Follow-Up | ||
|---|---|---|---|
| LVEDD, mm | 54.5 ± 6.6 | 49.0 ± 6.3 | <0.001 |
| LVESD, mm | 33.4 ± 7.0 | 35.6 ± 7.6 | <0.001 |
| LVEDVi mL/m2 | 71 ± 19 | 57 ± 17 | <0.001 |
| LVESVi, mL/m2 | 24 (19–31) | 25 (18–31) | 0.315 |
| LVEF, % | 65 ± 8 | 55 ± 11 | <0.001 |
| sPAP, mmHg | 32 (25–45) | 27 (23–33) | <0.001 |
| LAVi, mL/m2 | 56 ± 28 | 32 ± 17 | <0.001 |
| LASr, % | 23.6 ± 9.4 | 17.3 ± 7.5 | <0.001 |
Values are presented as mean ± SD, median (IQR). Abbreviations as in Table 1.
Univariate correlates of changes in LA volume and function at long-term follow-up after mitral valve repair.
| Change in LAVi at Long-Term Follow-Up | Change in LASr at Long-Term Follow-Up | |||
|---|---|---|---|---|
| Spearman’s Correlation Coefficient | Spearman’s Correlation Coefficient | |||
| Demographic characteristics | ||||
| Age, years | −0.139 | 0.037 | −0.364 | <0.001 |
| BMI, kg/m2 | −0.124 | 0.062 | 0.095 | 0.192 |
| Systolic BP, mmHg | 0.002 | 0.978 | −0.102 | 0.173 |
| Diastolic BP, mmHg | −0.057 | 0.402 | −0.057 | 0.448 |
| eGFR, mL/min/1.73 m2 | 0.062 | 0.358 | 0.236 | 0.001 |
| Pre-operative AF | 0.134 | 0.094 | 0.062 | 0.239 |
| Echocardiographic characteristics | ||||
| Preoperative LVEDVi, mL/m2 | 0.199 | 0.003 | 0.016 | 0.826 |
| Preoperative LVESVi, mL/m2 | 0.060 | 0.369 | −0.040 | 0.585 |
| Preoperative LVEF, % | 0.069 | 0.302 | 0.109 | 0.137 |
| Preoperative LAVi, mL/m2 | 0.498 | <0.001 | −0.319 | <0.001 |
| Preoperative LASr, % | 0.008 | 0.904 | 0.569 | <0.001 |
| Preoperative EROA, mm2 | 0.205 | 0.004 | 0.003 | 0.967 |
| Preoperative Rvol, ml | 0.222 | 0.002 | −0.171 | 0.030 |
| Postoperative TMPG immediate after intervention, mmHg | −0.150 | 0.026 | −0.068 | 0.361 |
AF = atrial fibrillation; BMI = body mass index; BP = blood pressure; eGFR = estimated glomerular filtration rate; EROA = effective regurgitant orifice area; LASr = left atrial reservoir strain; LAVi = left atrial volume index; LVEDVi = left ventricular end diastolic volume index; LVEF = left ventricular ejection fraction; LVESVi = left ventricular end systolic volume index; MR = mitral regurgitation; Rvol = regurgitant volume; TMPG = transmitral mean pressure gradient.
Figure 4Kaplan–Meier survival curve for all-cause mortality according to LAVi at long-term follow-up. Time to all-cause mortality according to LAVi at long-term follow-up: LAVi < 42 mL/m2 (blue) and LAVi ≥ 42 mL/m2 (red).
Cox regression analysis for all-cause mortality, starting from the long-term follow-up echocardiography.
| Univariable Analysis | Multivariable Analysis Adjusting for Age, Sex, CAD | Multivariable Analysis Adjusting for Age, Sex, LVEF | Multivariable Analysis Adjusting for Age, Sex, AF | |||||
|---|---|---|---|---|---|---|---|---|
| HR (95% CI) | HR (95% CI) | HR (95% CI) | HR (95% CI) | |||||
| LAVi, mL/m2 (continuous) | 1.021 (1.012–1.031) | <0.001 | 1.014 (1.001–1.027) | 0.033 | 1.014 (1.003–1.024) | 0.012 | 1.012 (1.001–1.023) | 0.027 |
| LAVi < 42 mL/m2 | Reference | Reference | Reference | Reference | ||||
| LAVi ≥ 42 mL/m2 | 3.729 (2.019–6.890) | <0.001 | 2.494 (1.292–4.815) | 0.006 | 2.518 (1.320–4.806) | 0.005 | 2.468 (1.295–4.704) | 0.006 |
AF = atrial fibrillation; CAD = coronary artery disease; CI = confidence interval; HR = hazard ratio; LAVi = left atrial volume index; LVEF = left ventricular ejection fraction.